Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yaxiong Zhang
Bevacizumab in Combination With Different Platinum-Based Doublets in the First-Line Treatment for Advanced Nonsquamous Non-Small-Cell Lung Cancer: A Network Meta-Analysis
International Journal of Cancer
Cancer Research
Oncology
Multi-Targeted Antiangiogenic Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer: Meta-Analyses of 20 Randomized Controlled Trials and Subgroup Analyses
PLoS ONE
Multidisciplinary
Related publications
Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Network Meta-Analysis
Immunotherapy
Oncology
Allergy
Immunology
Pcn44 - First-Line Treatment Efficacy in Egfr-Positive Non-Small Cell Lung Cancer: A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P3.01-70 Meta-Analysis of Metformin in Combination With Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis
Frontiers in Oncology
Cancer Research
Oncology
Redefining Treatment Paradigms in First-Line Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Bevacizumab Combination Chemotherapy in Clinical Practice for Advanced Non-Squamous Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Bevacizumab in the Treatment of Nonsquamous Non-Small Cell Lung Cancer: Clinical Trial Evidence and Experience
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Analysis of Continuous First‑line Treatment With Docetaxel and Carboplatin for Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
